Krabill, A.D.; Chen, H.; Hussain, S.; Hewitt, C.S.; Imhoff, R.D.; Muli, C.S.; Das, C.; Galardy, P.J.; Wendt, M.K.; Flaherty, D.P.
Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1. Molecules 2021, 26, 1227.
https://doi.org/10.3390/molecules26051227
AMA Style
Krabill AD, Chen H, Hussain S, Hewitt CS, Imhoff RD, Muli CS, Das C, Galardy PJ, Wendt MK, Flaherty DP.
Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1. Molecules. 2021; 26(5):1227.
https://doi.org/10.3390/molecules26051227
Chicago/Turabian Style
Krabill, Aaron D., Hao Chen, Sajjad Hussain, Chad S. Hewitt, Ryan D. Imhoff, Christine S. Muli, Chittaranjan Das, Paul J. Galardy, Michael K. Wendt, and Daniel P. Flaherty.
2021. "Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1" Molecules 26, no. 5: 1227.
https://doi.org/10.3390/molecules26051227
APA Style
Krabill, A. D., Chen, H., Hussain, S., Hewitt, C. S., Imhoff, R. D., Muli, C. S., Das, C., Galardy, P. J., Wendt, M. K., & Flaherty, D. P.
(2021). Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1. Molecules, 26(5), 1227.
https://doi.org/10.3390/molecules26051227